Oxidized lipoprotein(a) increases the expression of platelet-derived growth factor-B in human umbilical vein endothelial cells

Clinica Chimica Acta

Volumn 296, Issue 1-2, 2000, Pages 121-133

  Zhao, Shui ping ^a   Xu, Dan yan ^a  

^a Second Affil Hosp   (China)

Author keywords

Atherosclerosis; Oxidized lipoprotein(a); PDGF B

Indexed keywords

LIPOPROTEIN A; OXIDIZED LOW DENSITY LIPOPROTEIN; PLATELET DERIVED GROWTH FACTOR B;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTENOSIS; UMBILICAL VEIN;

CELL LINE; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HUMANS; KINETICS; LIPID PEROXIDATION; LIPOPROTEIN(A); LIPOPROTEINS, LDL; MALONDIALDEHYDE; OXIDATION-REDUCTION; PROTO-ONCOGENE PROTEINS C-SIS; RNA, MESSENGER; UMBILICAL VEINS;

EID: 0034010660     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(00)00214-X     Document Type: Article

References (38)

1. Thorgeirsson G., Robertson A.L., Lowan D.H., et al. Migration of human vascular endothelial and smooth muscle cells. Lab Invest. 41:1979;51-62.
2. Khachigian L.M., Chesterman C.N. Platelet-derived growth factor and its receptor: structure and roles in normal growth and pathology. Platelets. 4:1991;304-315.
3. Bowen-Pope D.F., Hart D., Seifart R.A., et al. Sera and conditioned media contain different isoforms of platelet-derived growth factor (PDGF) which bind to different classes of PDGF receptor. J Biol Chem. 264:1989;2502-2508.
4. Harlan J.M., Thrompson P.J., Ross R., et al. A-thrombin induces release of platelet-derived growth factor like molecule(s) by cultured human endothelial cells. J Cell Biol. 103:1986;1129-1133.
5. Daniel T.O., Gibbs V.C., Milfay D.F., et al. Thrombin stimulates c-sis gene expression in microvascular endothelial cells. J Biol Chem. 261:1986;9579-9582.
6. Daniel T.O., Gibbs V.C., Milfay D.F., et al. Agents that increase cAMP accumulation block endothelial c-sis induction by thrombin and transforming growth factor-B. J Biol Chem. 262:1987;11893-11896.
7. Kourembanas S., Faller D.V. Platelet-derived growth factor production by human umbilical vein endothelial cells is regulated by basic fibroblast growth factor. J Biol Chem. 264:1989;4456-4459.
8. Berk B.C. Vasoconstriction: a new activity for PDGF. Science. 232:1986;87.
9. Ross R., Bawen-Pope D.F., Raines E.W., et al. Platelet-derived growth factor and its role in health and disease. Philosoph Trans R Soc London B Biol Sci. 327:1990;155-169.
10. Ross R., Masuda J., Raines E.W., et al. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science. 248:1990;1009-1012.
11. Barrett T.B., Benditt E.P. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc Natl Acad Sci USA. 85:1988;2810-2814.
12. Barrett T.B., Benditt E.P. Sis (platelet-derived growth factor B chain) gene transcript levels are elevated in human atherosclerotic lesions compared to normal artery. Proc Natl Acad Sci USA. 84:1987;1099-1103.
13. Billett M.A., Adbeish I.S., Salman A.H., et al. Increased expression of genes for platelet derived growth factor in circulating mononuclear cells of hypercholesterolemic patients. Arterioscler Thromb Vasc Biol. 16:1996;399-406.
14. Thomas E., Carew T.E. Role of biologically modified low density lipoprotein in atherosclerosis. Am J Cardiol. 64:1989;18G-22G.
15. Michael E. Oxidized LDL affects multiple atherogenic cellular responses. Circulation. 83:1991;2137-2140.
16. Malden L.T., Chalt A., Raines E.W., et al. The influence of oxidatively modified low density lipoproteins on expression of platelet-derived growth factor by human monocyte-derived macrophages. J Biol Chem. 266:1991;13901-13907.
17. Fogelman A.M., Elahi F., Sykes K., et al. Modification of the Recalde method for the isolation of human monocytes. J Lipid Res. 29:1988;1243.
18. Redgrave T.G., Roberts D.K., West C.E., et al. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal Biochem. 65:1975;42-49.
19. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
20. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 95:1979;351-358.
21. Pigott R., Neodham L.A., Edwards R.M., et al. Structural and functional studies of the endothelial activation antigen endothelial leukocyte adhesion molecule-1 using a panel of monoclonal antibodies. J Immunol. 147:1991;130-135.
22. Nilsson J., Volk-Jovinge S., Svensson J., et al. Association between high levels of growth factors plasma and progression of coronary atherosclerosis. J Intern Med. 232:1992;397-404.
23. Kariya K., Kawahara Y., Tsuda T., et al. Possible involvement of protein kinase C in platelet derived growth factor stimulated DNA synthesis in vascular smooth muscle cells. Atherosclerosis. 63:1987;251-255.
24. Grofendorst G.R., Chang T., Seppae H.E.J., et al. Platelet-derived growth factor is a chemoattractant for vascular smooth muscles cells. J Cell Physiol. 113:1981;261-266.
25. Bath P.M.W., Martin F. Serum platelet-derived growth factor and endothelin concentrations in human hypercholesterolemia. J Inter Med. 230:1991;313-317.
26. Ross R. The pathogenesis of atherosclerosis: an update. New Engl J Med. 314:1986;488-500.
27. Ultermann G. The mysteries of lipoprotein (a). Science. 246:1989;904-910.
28. Hoff H.F. Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation. 77:1988;1238-1244.
29. Grainger D.J., Kirschenlohr H.L., Metcalfe J.C., et al. Proliferation of human smooth muscle cells promoted by lipoprotein (a). Science. 260:1993;1655-1657.
30. Parthasarathy S. Oxidized low density lipoprotein, a two-faced janus in coronary artery disease? Biomchem Pharmacol. 56:1998;279-284.
31. Naruszewicz M., Selinger E., Davignon J., et al. Oxidative modification of lipoprotein (a) and the effect of β-carotene. Metabolism. 41:1992;1215-1224.
32. Jurgen S.G., Chen Q., Esterbauer H., et al. Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apolipoprotein(a). Arterioscler Thromb. 13:1993;1689-1699.
33. Ross R. Atherosclerosis - an inflammatory disease. New Engl J Med. 340:1999;115-126.
34. Parthasarathy S., Steinbrecher U., Barnett J., et al. Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci USA. 82:1985;3000-3004.
35. Yokoyama M., Hirata K., Miyake R., et al. Lysophosphatidylcholine: Essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem Biophys Res Commun. 168:1990;301-308.
36. Esterbauer H., Jurgens G., Quehenberger O., et al. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J Lipid Res. 28:1987;495-509.
37. Gave J., Bengen J., Schollmeyer P., et al. Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein (a): Role of oxygen derived radicals. Circulation. 92:1995;1582-1589.
38. Galle J., Schneider R., Heinloth A., et al. Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: Role of oxidative stress. Kidney Int. 5:1999;1450-1461.